Category: Uncategorized

We recently attended an insightful seminar on biotech manufacturing that we’d like to share with you. On September 13, 2024,

The expedited drug approval process by the U.S. Food and Drug Administration (FDA) is a double-edged sword. Designed to bring

The National Venture Capital Association (“NVCA”) has innovated again in venture capital. They’ve updated their standard template legal documents, a

Great news for prevention of respiratory syncytial virus (“RSV”) infections! Here’s a quick summary of the article: RSV is a common

Have you ever heard of a tar baby? In the 1946 Disney animated film “Song of the South” (now banned

Big news on the legal front! The U.S. District Court for Northern Alabama has just ruled that the Federal Corporate Transparency Act

We are delighted to report a new recognition for Nariman Farvardin, President of Stevens Institute of Technology. He is to

Artificial intelligence systems will be the savior of mankind! Artificial intelligence systems will doom mankind! Which statement is true??  Who knows

The BioNJ 31st Annual Dinner Meeting and Innovation Celebration, held on February 8, 2024, was a significant event that showcased

Sometimes a technical innovation fails to deliver improved patient outcomes. An example may be robotic-assisted knee replacements. Robotic-assisted knee replacements,

Did you know that the Federal government could be your “partner” in ownership of your patent rights? That could happen

Stage2Startups has a wonderful focus. It seeks to help “mature” entrepreneurs who have had a lot of “life experience” start new

I’m happy to send congratulations to my friend and colleague, Lisa Policare, CEO of Penn Wealth Planning on being recognized

Small privately-held companies will have new compliance burdens starting in the new year. The Federal Corporate Transparency Act (“CTA”) will

Bio NJ has some tremendous opportunities for C-suite executives at life sciences companies. Bio NJ has established a networking and

Here’s a great opportunity for those interested in biomedical research and entrepreneurship. The Biomedical Engineering Department at Stevens Institute of Technology

Orphan drug development is a crucial and complex area of pharmaceutical research. It’s dedicated to creating treatments for rare diseases.

Losing one’s sight is one of the cruelest types of disabilities.  We depend on that sense for so much of

A significant new reporting requirement started on January 1, 2024. The Federal Corporate Transparency Act requires that most small limited

I’m sending congratulations to my friends and fellow lawyers, Ralph Selitto and John Kim. Both are experienced intellectual property lawyers

The realm of medical devices has seen remarkable advancements in 2023. Innovators need to be aware of these advancements to

Key Highlights: ·        Strategic Shift: CRISPR Therapeutics is pivoting from cancer drug development to cell-based medicines for autoimmune

It’s not just your hometown physician’s travel bag anymore! In the dynamic field of life sciences, cell and gene therapy

One of the features that excites me about representing life sciences and other technology innovators is the impact they can